2023’s best medtech innovations
Category: Best Medical Technology
Nominee: Edwards Lifesciences’ Sapien 3 Ultra Resilia Transcatheter Aortic Heart Valve
The transcatheter aortic valve replacement (TAVR) device uses Resilia, a bovine pericardial tissue treated with anti-calcification technology. The tissue provides enhanced calcium-blocking properties and dry tissue packaging conditions that facilitate ease of use, Edwards said.
That anti-calcification technology “addresses one of the primary causes of reintervention following heart valve replacement,” said Edwards TAVR executive Larry Wood.
“The Sapien 3 Ultra Resilia valve builds on Edwards’ 40 years of leadership in tissue technology by combining advancements in tissue science with the industry-leading Sapien 3 Ultra valve to offer the only dry storage transcatheter heart valve on the U.S. market today,” he said in a news release announcing the product launch.